GNC Holdings Inc (GNC) 46.77 $GNC Billion Dollar Omega-3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
GNC Holdings Inc (GNC) 46.77 $GNC

Billion Dollar Omega-3 Fish Oil Market Forecasted to Continue to Grow - Company Receives FDA Approval for High Potency Omega-3 Recovery Supplements
PR Newswire - Mon Mar 16, 7:40AM CDT
The global market for fish oil omega-3 is projected to grow from $1.1 billion in 2011 to $1.7 billion by 2018. Globally rising awareness about the importance of omega-3 fatty acids - of which fish oil is a primary source - for several purposes in the human body, is an important driver of the global market for fish oil. Nutrition & Supplement Companies in focus today are: Axxess Pharma Inc. (OTC: AXXE), MusclePharm Corporation (OTC: MSLP), GNC Holdings, Inc. (NYSE: GNC), Herbalife Ltd. (NYSE: HLF) and Amarin Corporation Plc (NASDAQ: AMRN).
HLF: 42.10 (+4.16), AMRN: 2.52 (-0.03), GNC: 46.77 (+1.04)

Is Herbalife Actually Selling Anything?
Dana Blankenhorn - at Seeking Alpha - Sat Mar 14, 12:11PM CDT

HLF: 42.10 (+4.16), VSI: 40.58 (-0.04), GNC: 46.77 (+1.04)

GNC Holdings (GNC) Stock Gaining Today on Morgan Stanley Upgrade
at The Street - Thu Mar 12, 8:48AM CDT
GNC Holdings (GNC) stock is higher this morning after the company had its rating raised to 'overweight' from 'equal weight' at Morgan Stanley.
GNC: 46.77 (+1.04)

GNC Holdings (GNC) Marked As A Dead Cat Bounce Stock
at The Street - Wed Mar 11, 8:53AM CDT
Trade-Ideas LLC identified GNC Holdings (GNC) as a "dead cat bounce" (down big yesterday but up big today) candidate
GNC: 46.77 (+1.04)

GNC
at Investor's Business Daily - Tue Mar 10, 5:47PM CDT
GNC (GNC) and Vitamin Shoppe (VSI) shares plummeted as N.Y. State Att'y Gen. Eric T. Schneiderman widened the probe into the herbal supplement industry. GNC shares plunged 8.5% to 44.83. Vitamin Shoppe shares fell 4.8% to 40.35.
VSI: 40.58 (-0.04), GNC: 46.77 (+1.04)

GNC Holdings (GNC) Stock Rebounding in After-Hours After Meeting Regulatory Requirements
at The Street - Tue Mar 10, 5:37PM CDT
GNC Holdings (GNC) stock is sharply up late Tuesday after the retailer said its products are in full compliance with regulatory requirements.
GNC: 46.77 (+1.04)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against GNC Holdings Inc.
Business Wire - Tue Mar 10, 5:28PM CDT
The Rosen Law Firm, P.A., a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of GNC Holdings Inc. (NYSE:GNC) resulting from allegations that GNC may have issued materially misleading business information to the investing public.
GNC: 46.77 (+1.04)

GNC, Vitamin Shoppe Shares Fall As NY Probe Widens
at Investor's Business Daily - Tue Mar 10, 3:32PM CDT
Shares of nutrition retailers GNC (GNC) and Vitamin Shoppe plunged on Tuesday after New York State Attorney General Eric T. Schneiderman announced a wider investigation into "potentially false and misleading business practices" of the herbal...
VSI: 40.58 (-0.04), WBA: 88.23 (+0.87), GNC: 46.77 (+1.04), TGT: 81.31 (+0.71), WMT: 83.24 (+1.72)

GNC Announces Independent, Third Party Test Results Conclusively Confirming Safety, Quality, Purity and Proper Labeling in Herbal Plus(R) Product Line
Business Wire - Tue Mar 10, 3:05PM CDT
--Products Have Now Been Tested Four Times, Yielding Same Results
GNC: 46.77 (+1.04)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GNC Holdings, Inc.
Business Wire - Tue Mar 10, 1:13PM CDT
Pomerantz LLP is investigating claims on behalf of investors of GNC Holdings, Inc. ("GNC" or the "Company" (NYSE:GNC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
GNC: 46.77 (+1.04)

GNC Holdings (GNC) Stock Down Today as Attorneys General Probe Supplement Industry
at The Street - Tue Mar 10, 10:37AM CDT
GNC Holdings (GNC) stock is down as a group of State Attorney Generals investigate the industry's business practices.
WBA: 88.23 (+0.87), GNC: 46.77 (+1.04), TGT: 81.31 (+0.71), WMT: 83.24 (+1.72)

Coalition of state attorneys general to probe herbal supplement makers
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 9:53AM CDT

HLF: 42.10 (+4.16), VSI: 40.58 (-0.04), GNC: 46.77 (+1.04)

Preliminary FitLife FY2014 Earnings Confirm My Fears
Paulo Santos - at Seeking Alpha - Wed Feb 25, 11:10AM CST

GNC: 46.77 (+1.04)

It Is Too Early To Bank On A Turnaround At GNC Holdings
George Hanley - at Seeking Alpha - Tue Feb 24, 12:00AM CST

GNC: 46.77 (+1.04)

Ryan & Maniskas, LLP Announces Investigation of GNC Holdings Inc.
PR Newswire - Wed Feb 18, 5:13PM CST
Ryan & Maniskas, LLP has commenced an investigation into potential securities law violations by certain officers of GNC Holdings Inc. ("GNC" or the "Company" (NYSE: GNC).
GNC: 46.77 (+1.04)

Technical Coverage on Specialty Retail Stocks -- GNC Holdings, Sally Beauty Holdings, Michaels Cos., bebe stores, and Rent-A-Center
PR Newswire - Tue Feb 17, 8:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
BEBE: 3.53 (-0.09), RCII: 28.10 (+0.52), GNC: 46.77 (+1.04), SBH: 34.49 (+0.05), MIK: 29.92 (+0.50)

Factors Moving Markets: Special Research on Orbitz, Tripadvisor, First American Financial, McGraw Hill, and GNC Holdings
PR Newswire - Fri Feb 13, 7:30AM CST
Editor Note: For more information about this release, please scroll to bottom.
GNC: 46.77 (+1.04), TRIP: 86.35 (+2.55), FAF: 35.38 (+0.10), MHFI: 108.59 (+1.08), OWW: 11.77 (-0.02)

GNC Holdings posts lower Q4 2014 adjusted net income of USD53.9m
M2 - Fri Feb 13, 4:28AM CST
Health company GNC Holdings (NYSE:GNC) stated on Thursday its adjusted net income of USD53.9m for the fourth quarter period ended 31 December 2014.
GNC: 46.77 (+1.04)

GNC Q4 EPS falls but still tops
at Investor's Business Daily - Thu Feb 12, 5:30PM CST
The vitamin store's EPS fell 3.2% to 61 cents but beat views by 2 cents. Revenue dipped 0.7% to $607.2 mil, topping views for $599.4 mil. Same-store sales in domestic company-owned stores and at website GNC.com decreased 3%. Domestic franchise...
GNC: 46.77 (+1.04)

Why GNC Holdings Inc's Shares Bulked Up Today
Alex Planes, The Motley Fool - Motley Fool - Thu Feb 12, 4:56PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of GNC Holdings closed Thursday up more than...
GNC: 46.77 (+1.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

DCHFA Appoints Dr. Moreiça Allana-Kim Ortega for Strategic Leadership

Updated Category News Views 325

DCHFA Welcomes Dr. Moreiça Allana-Kim Ortega The District of Columbia Housing Finance Agency (DCHFA) has announced an exciting new direction by creating an Office of Strategic Planning and Performance, under the leadership of Dr. Moreiça Allana-Kim Ortega. This new office is aimed at enhancing the effectiveness of the agency by addressing the evolving needs of housing...

Continue Reading
Cboe Hits Milestone of 1,000 ETFs, Showcasing Growth Trend

Updated Category News Views 120

Cboe Achieves Major Milestone in ETF Listings Cboe Global Markets, Inc. (Cboe: CBOE) has achieved a remarkable feat by surpassing 1,000 U.S.-listed exchange-traded funds (ETFs). This notable accomplishment underscores Cboe's position as a premier venue for innovative actively-managed ETFs. The exchange has welcomed an impressive number of 185 new U.S. ETFs this year,...

Continue Reading
Eat Happy Kitchen Expands Reach with Nationwide Kroger Partnership

Updated Category News Views 1256

Eat Happy Kitchen Expands Retail Presence Nationally In an exciting development for health-conscious shoppers, Eat Happy Kitchen has significantly expanded its reach across the U.S. Nearly 500 stores under the Kroger family umbrella will now feature the woman-owned brand's all-natural line of pasta sauces. This rapid expansion is a testament to the growing demand for...

Continue Reading
ThreeD Capital Reveals December Net Asset Value of $0.76

Updated Category News Views 183

Understanding ThreeD Capital's Recent NAV Announcement ThreeD Capital Inc. is a venture capital firm that carefully evaluates its financial standing to provide clarity to its stakeholders. Recently, the company disclosed that its unaudited net asset value (NAV) per share was valued at $0.76 as of December 31, 2024. This announcement reflects ThreeD’s commitment to...

Continue Reading
Innovative Wealth Planning Tool by Simon Quick Advisors Unveiled

Updated Category News Views 112

Simon Quick Advisors Introduces WealthMetrx™ for Tax Efficiency Simon Quick Advisors, a leading independent wealth management firm, has unveiled a new service called WealthMetrx™. This innovative approach aims to offer clients a comprehensive understanding of their tax profile by transforming intricate data into practical insights. With WealthMetrx™, clients can...

Continue Reading